resveratrol has been researched along with Bone Loss, Osteoclastic in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 3 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cancela, ML; Gavaia, PJ; Martins, G; Poudel, S | 1 |
| Ichimaru, R; Inada, M; Ishimi, Y; Kondo, T; Miyaura, C; Tousen, Y | 1 |
| Deng, L; Fan, J; Zhang, Y | 1 |
| Chen, KM; Hassanshahi, M; Howe, PR; Su, YW; Tang, Q; Xian, CJ | 1 |
| Barralet, J; Blanco, L; Eimar, H; Tamimi, F; Torres, J; Tresguerres, IF; Tresguerres, JA | 1 |
| Cristina Orihuela-Campos, R; Fukui, M; Inagaki, Y; Ito, HO; Nagata, T; Tamaki, N | 1 |
| Frendo-Cumbo, S; Holloway, GP; Miotto, PM; Sacco, SM; Ward, WE; Wright, DC | 1 |
| Kim, BJ; Kim, GH; Kim, GS; Kim, SW; Kim, YS; Koh, JM; Lee, KU; Lee, SH; Lee, SY; Lee, YS | 1 |
| Kupisiewicz, K | 1 |
2 review(s) available for resveratrol and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Childhood cancer chemotherapy-induced bone damage: pathobiology and protective effects of resveratrol and other nutraceuticals.
Topics: Antimetabolites, Antineoplastic; Bone Resorption; Cell Differentiation; Child; Dietary Supplements; Humans; Methotrexate; Neoplasms; Protective Agents; Resveratrol; Stilbenes | 2017 |
Biological aspects of altered bone remodeling in multiple myeloma and possibilities of pharmacological intervention.
Topics: Antineoplastic Agents, Phytogenic; Bone and Bones; Bone Remodeling; Bone Resorption; Boronic Acids; Bortezomib; Calcium-Binding Proteins; Humans; Intercellular Signaling Peptides and Proteins; Membrane Proteins; Multiple Myeloma; Osteoblasts; Osteoclasts; Protease Inhibitors; Pyrazines; Resveratrol; Signal Transduction; Stilbenes; Wnt Proteins | 2011 |
7 other study(ies) available for resveratrol and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Resveratrol-Mediated Reversal of Doxorubicin-Induced Osteoclast Differentiation.
Topics: Animals; Antioxidants; Bone Resorption; Cell Differentiation; Doxorubicin; NFATC Transcription Factors; Osteoclasts; Osteogenesis; RANK Ligand; Resveratrol; Zebrafish | 2022 |
The Combination of Soy Isoflavones and Resveratrol Preserve Bone Mineral Density in Hindlimb-Unloaded Mice.
Topics: Animals; Body Weight; Bone Density; Bone Density Conservation Agents; Bone Marrow Cells; Bone Resorption; Calcification, Physiologic; Eating; Female; Femur; Gene Expression; Glycine max; Hindlimb; Hindlimb Suspension; Isoflavones; Mice; Random Allocation; RANK Ligand; Resveratrol; RNA, Messenger; Serum Albumin; Tibia; X-Ray Microtomography | 2020 |
Effects of resveratrol on bone metabolism and bone turnover related indexes in ovariectomized osteoporosis rats.
Topics: Alkaline Phosphatase; Animals; Bone and Bones; Bone Density; Bone Remodeling; Bone Resorption; Female; Osteocalcin; Osteogenesis; Osteoporosis; Ovariectomy; Phosphorus; Rats; Rats, Sprague-Dawley; Resveratrol | 2020 |
Resveratrol as anti-aging therapy for age-related bone loss.
Topics: Aging; Animals; Biomarkers; Biomechanical Phenomena; Body Weight; Bone Resorption; Collagen Type I; Femur; Male; Organ Size; Osteocalcin; Peptides; Rats, Wistar; Rejuvenation; Resveratrol; Stilbenes; X-Ray Microtomography | 2014 |
Resveratrol improves oxidative stress and prevents the progression of periodontitis via the activation of the Sirt1/AMPK and the Nrf2/antioxidant defense pathways in a rat periodontitis model.
Topics: 8-Hydroxy-2'-Deoxyguanosine; AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents; Antioxidants; Bone Resorption; Cytokines; Deoxyguanosine; Disease Models, Animal; Gingiva; Inflammation; Male; NF-E2-Related Factor 2; Nitric Oxide; Oxidative Stress; Periodontitis; Random Allocation; Rats; Rats, Wistar; Resveratrol; Sirtuin 1; Stilbenes; Tyrosine | 2014 |
Combined high-fat-resveratrol diet and RIP140 knockout mice reveal a novel relationship between elevated bone mitochondrial content and compromised bone microarchitecture, bone mineral mass, and bone strength in the tibia.
Topics: Adaptor Proteins, Signal Transducing; Animals; Body Weight; Bone Density; Bone Resorption; Diet, High-Fat; Male; Mice, Inbred C57BL; Mice, Knockout; Mitochondria; Nuclear Proteins; Nuclear Receptor Interacting Protein 1; Osteoclasts; RANK Ligand; Resveratrol; Stilbenes; Tibia | 2016 |
AMP kinase acts as a negative regulator of RANKL in the differentiation of osteoclasts.
Topics: Adenylate Kinase; Animals; Apoptosis; Blotting, Western; Bone Resorption; Catechin; Cell Differentiation; Cell Survival; Cells, Cultured; Macrophage Colony-Stimulating Factor; MAP Kinase Kinase Kinases; Metformin; Mice; Mice, Inbred ICR; Osteoclasts; Osteogenesis; Pyrazoles; Pyrimidines; RANK Ligand; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Stilbenes | 2010 |